That it should be the policy of the U.S. Government to encourage and facilitate as feasible:
The Secretary of Health and Human Services shall enter into negotiations with the World Health Organization to develop a Global Alzheimer's and Dementia Action Plan focused on the following areas:
Research, including clinical research and clinical trials, and regulatory issue;
Clinical care;
Supportive services for patients and for caregivers, including supports using innovative technologies;
Clinical care;
Supportive services for patients and for caregivers, including supports using innovative technologies;
Prevention and health promotion;
Development of a stable and sustained international commitment to Alzheimer's research, and
Public awareness and education, particularly efforts aimed at reducing stigmas and increasing the inclusion of persons with Alzheimer's and dementia within civil society.
In addition to the WHO, the effort should involve all other nations that have adopted national Alzheimer's and/or dementia plans or strategies and, to the greatest extent possible, connect to components of one or more of said plans. Nations without plans yet willing to participate in developing the global strategy can do so if they commit to providing resources to fund the effort.
The Secretary of Health and Human Services along with the Secretary of the Treasury should develop the foundation for a Global Alzheimer's Fund that would provide resources to support implementation of specific strategies of the Global Plan. This early-stage effort shall include:
Priority areas of focus,
Governance structure and
Participation of other government, private entities and non-governmental organizations
The G8 nations, working with the G20, G77 and other forums including the Organization for Economic Cooperation and Development (OECD) should investigate systems to monitor and provide care to persons with Alzheimer's and other forms of dementia in developing countries to help build care delivery capacity.
The U.S. Agency for International Development, in collaboration with all other relevant U.S. agencies, should investigate the foreign aid implications of Alzheimer's and other forms of dementia and inform Congress as to the need for possible changes to foreign healthcare-related foreign assistance.
In order to maximize the possibility of successful treatment for Alzheimer's and other forms of dementia, the U.S. government should encourage and facilitate partnerships with the private sector, such as the current partnership between the National Institutes of health and 10 pharmaceutical companies to identify new approaches to treat Alzheimer's and other medical conditions.